Impact of Stratified Randomization in Clinical Trials
被引:3
|
作者:
Anisimov, Vladimir V.
论文数: 0引用数: 0
h-index: 0
机构:
GlaxoSmithKline, Stat Res Unit, New Frontiers Sci Pk South,Third Ave, Harlow CM19 5AW, Essex, EnglandGlaxoSmithKline, Stat Res Unit, New Frontiers Sci Pk South,Third Ave, Harlow CM19 5AW, Essex, England
Anisimov, Vladimir V.
[1
]
机构:
[1] GlaxoSmithKline, Stat Res Unit, New Frontiers Sci Pk South,Third Ave, Harlow CM19 5AW, Essex, England
来源:
MODA 9 - ADVANCES IN MODEL-ORIENTED DESIGN AND ANALYSIS
|
2010年
关键词:
D O I:
10.1007/978-3-7908-2410-0_1
中图分类号:
O21 [概率论与数理统计];
C8 [统计学];
学科分类号:
020208 ;
070103 ;
0714 ;
摘要:
This paper deals with the analysis of randomization effects in clinical trials. The two randomization schemes most often used are considered: unstratified and stratified block-permuted randomization. A new analytic approach using a Poisson-gamma patient recruitment model and its further extensions is proposed. The prediction of the number of patients randomized in different strata to different treatment arms is considered. In the case of two treatments, the properties of the total imbalance in the number of patients on treatment arms caused by using stratified randomization are investigated and for a large number of strata a normal approximation of imbalance is proved. The impact of imbalance on the power of the trial is considered. It is shown that the loss of statistical power is practically negligible and can be compensated by a minor increase in sample size. The influence of patient dropout is also investigated.
机构:
GlaxoSmithKline Inc, Stat Res Unit, NFSP S, Harlow CM19 5AW, Essex, EnglandGlaxoSmithKline Inc, Stat Res Unit, NFSP S, Harlow CM19 5AW, Essex, England